We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

102 hedge funds and large institutions have $129M invested in VanEck Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 7

112% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $646K

77% more capital invested

Capital invested by funds: $73M → $129M (+$56.4M)

75% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 16

23% more funds holding

Funds holding: 83 → 102 (+19)

4.58% more ownership

Funds ownership: 22.78% → 27.36% (+4.6%)

Holders
102
Holders Change
+19
Holders Change %
+22.89%
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
28
Reduced
16
Closed
7
Calls
$1.37M
Puts
$646K
Net Calls
+$723K
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
+$17.7M
2
Morgan Stanley
Morgan Stanley
New York
+$3.36M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25M
4
LPL Financial
LPL Financial
California
+$2.05M
5
BRC
BHF RG Capital
Arizona
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4.57M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$440K
3
UBS Group
UBS Group
Switzerland
-$361K
4
SBH
Segall Bryant & Hamill
Illinois
-$251K
5
CG
Caprock Group
Idaho
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
KPCM
76
Kings Point Capital Management
New York
$44K – – –
TC
77
Truvestments Capital
Florida
$44K +$41.8K +275 New
Northwestern Mutual Wealth Management
78
Northwestern Mutual Wealth Management
Wisconsin
$42K +$38.8K +255 New
TRCT
79
Tower Research Capital (TRC)
New York
$42K +$39.5K +260 New
AF
80
Arrow Financial
New York
$41K – – –
APWM
81
Atlas Private Wealth Management
New York
$40K – – –
FHA
82
Flagship Harbor Advisors
Massachusetts
$40K – – –
GFPC
83
Global Financial Private Client
Florida
$31K -$77.7K -511 -73%
AIM
84
Anchor Investment Management
South Carolina
$25.3K – – –
HNB
85
Huntington National Bank
Ohio
$25K – – –
Fidelity Investments
86
Fidelity Investments
Massachusetts
$24K -$34.6K -228 -60%
Carson Wealth (CWM LLC)
87
Carson Wealth (CWM LLC)
Nebraska
$24K – – –
US Bancorp
88
US Bancorp
Minnesota
$24K – – –
LWM
89
Lenox Wealth Management
Ohio
$24K +$23.3K +153 New
APA
90
American Portfolios Advisors
New York
$20.4K +$3.8K +25 +25%
WT
91
Whittier Trust
California
$16K -$15.2K -100 -50%
FWM
92
FSA Wealth Management
Massachusetts
$16K – – –
M
93
MOTCO
Texas
$16K – – –
FP
94
Financial Perspectives
Minnesota
$14.3K – – –
CAPTRUST Financial Advisors
95
CAPTRUST Financial Advisors
North Carolina
$13K +$12K +79 New
PWP
96
Principle Wealth Partners
Connecticut
$13K +$12K +79 New
CFA
97
Carroll Financial Associates
North Carolina
$12K – – –
ADL
98
Asset Dedication LLC
California
$10K +$9.12K +60 New
AF
99
Allworth Financial
California
$5K +$4.86K +32 New
AIP
100
Ameritas Investment Partners
Nebraska
$3K – – –
1 2 3
4
5

BBH Hedge Fund Activity: Q2 2020 in Review

102 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2020, worth a combined $129M — up 77% from $73M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BBH positions and 7 closed out — a net gain of 19 holders — while 28 added to existing stakes and 16 trimmed.

The largest buyer was Pinnacle Advisory Group, adding an estimated $17.7M. The largest seller was Bank of America, cutting an estimated $4.57M.

  • 102 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2020, up from 83 in Q1 2020.
  • Funds reported $129M of VanEck Biotech ETF stock for Q2 2020, up 77% quarter-over-quarter.
  • 26 funds opened new VanEck Biotech ETF positions in Q2 2020 and 7 closed out, a net change of +19 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2020 was Pinnacle Advisory Group, an estimated $17.7M added.
  • The largest VanEck Biotech ETF seller in Q2 2020 was Bank of America, an estimated $4.57M sold.

Based on aggregated 13F filings for Q2 2020.